245 related articles for article (PubMed ID: 25560767)
1. Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo.
Sampson AK; Irvine JC; Shihata WA; Dragoljevic D; Lumsden N; Huet O; Barnes T; Unger T; Steckelings UM; Jennings GL; Widdop RE; Chin-Dusting JP
Br J Pharmacol; 2016 Feb; 173(4):729-40. PubMed ID: 25560767
[TBL] [Abstract][Full Text] [Related]
2. The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis.
Chow BS; Koulis C; Krishnaswamy P; Steckelings UM; Unger T; Cooper ME; Jandeleit-Dahm KA; Allen TJ
Diabetologia; 2016 Aug; 59(8):1778-90. PubMed ID: 27168137
[TBL] [Abstract][Full Text] [Related]
3. C21 preserves endothelial function in the thoracic aorta from DIO mice: role for AT2, Mas and B2 receptors.
González-Blázquez R; Alcalá M; Fernández-Alfonso MS; Steckelings UM; Lorenzo MP; Viana M; Boisvert WA; Unger T; Gil-Ortega M; Somoza B
Clin Sci (Lond); 2021 May; 135(9):1145-1163. PubMed ID: 33899912
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin AT2-receptor stimulation improves survival and neurological outcome after experimental stroke in mice.
Schwengel K; Namsolleck P; Lucht K; Clausen BH; Lambertsen KL; Valero-Esquitino V; Thöne-Reineke C; Müller S; Widdop RE; Denton KM; Horiuchi M; Iwai M; Boato F; Dahlöf B; Hallberg A; Unger T; Steckelings UM
J Mol Med (Berl); 2016 Aug; 94(8):957-66. PubMed ID: 26983606
[TBL] [Abstract][Full Text] [Related]
5. Direct stimulation of angiotensin II type 2 receptor reduces nitric oxide production in lipopolysaccharide treated mouse macrophages.
Isaksson R; Casselbrant A; Elebring E; Hallberg M; Larhed M; Fändriks L
Eur J Pharmacol; 2020 Feb; 868():172855. PubMed ID: 31837306
[TBL] [Abstract][Full Text] [Related]
6. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
Sato K; Shirai R; Hontani M; Shinooka R; Hasegawa A; Kichise T; Yamashita T; Yoshizawa H; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411243
[TBL] [Abstract][Full Text] [Related]
7. Role of interleukin-10 in the neuroprotective effect of the Angiotensin Type 2 Receptor agonist, compound 21, after ischemia/reperfusion injury.
Fouda AY; Pillai B; Dhandapani KM; Ergul A; Fagan SC
Eur J Pharmacol; 2017 Mar; 799():128-134. PubMed ID: 28192099
[TBL] [Abstract][Full Text] [Related]
8. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
[TBL] [Abstract][Full Text] [Related]
9. Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB.
Rompe F; Artuc M; Hallberg A; Alterman M; Ströder K; Thöne-Reineke C; Reichenbach A; Schacherl J; Dahlöf B; Bader M; Alenina N; Schwaninger M; Zuberbier T; Funke-Kaiser H; Schmidt C; Schunck WH; Unger T; Steckelings UM
Hypertension; 2010 Apr; 55(4):924-31. PubMed ID: 20157051
[TBL] [Abstract][Full Text] [Related]
10. Possible synergistic effect of direct angiotensin II type 2 receptor stimulation by compound 21 with memantine on prevention of cognitive decline in type 2 diabetic mice.
Iwanami J; Mogi M; Tsukuda K; Jing F; Ohshima K; Wang XL; Nakaoka H; Kan-no H; Chisaka T; Bai HY; Min LJ; Horiuchi M
Eur J Pharmacol; 2014 Feb; 724():9-15. PubMed ID: 24361310
[TBL] [Abstract][Full Text] [Related]
11. Vascular angiotensin II type 2 receptor attenuates atherosclerosis via a kinin/NO-dependent mechanism.
Takata H; Yamada H; Kawahito H; Kishida S; Irie D; Kato T; Wakana N; Miyagawa S; Fukui K; Matsubara H
J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):311-20. PubMed ID: 23736171
[TBL] [Abstract][Full Text] [Related]
12. Lipocalin-2 exerts pro-atherosclerotic effects as evidenced by in vitro and in vivo experiments.
Shibata K; Sato K; Shirai R; Seki T; Okano T; Yamashita T; Koide A; Mitsuboshi M; Mori Y; Hirano T; Watanabe T
Heart Vessels; 2020 Jul; 35(7):1012-1024. PubMed ID: 31960147
[TBL] [Abstract][Full Text] [Related]
13. AT
Lange C; Sommerfeld M; Namsolleck P; Kintscher U; Unger T; Kaschina E
Hypertension; 2018 Sep; 72(3):e20-e29. PubMed ID: 29987108
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of the angiotensin II AT
Bennion DM; Jones CH; Dang AN; Isenberg J; Graham JT; Lindblad L; Domenig O; Waters MF; Poglitsch M; Sumners C; Steckelings UM
Clin Sci (Lond); 2018 Mar; 132(5):581-593. PubMed ID: 29500223
[TBL] [Abstract][Full Text] [Related]
15. Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.
Bruce E; Shenoy V; Rathinasabapathy A; Espejo A; Horowitz A; Oswalt A; Francis J; Nair A; Unger T; Raizada MK; Steckelings UM; Sumners C; Katovich MJ
Br J Pharmacol; 2015 May; 172(9):2219-31. PubMed ID: 25522140
[TBL] [Abstract][Full Text] [Related]
16. The Selective Angiotensin II Type 2 Receptor Agonist Compound 21 Reduces Abdominal Adhesions in Mice.
Boudreau C; LeVatte T; Jones C; Gareau A; Legere S; Bezuhly M
J Surg Res; 2020 Dec; 256():231-242. PubMed ID: 32711180
[TBL] [Abstract][Full Text] [Related]
17. The anti-fibrotic actions of relaxin are mediated through AT
Wang C; Pinar AA; Widdop RE; Hossain MA; Bathgate RAD; Denton KM; Kemp-Harper BK; Samuel CS
FASEB J; 2020 Jun; 34(6):8217-8233. PubMed ID: 32297670
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of trans-caryophyllene (TC) on leukocyte-endothelial attachment.
Zhang Z; Yang C; Dai X; Ao Y; Li Y
Toxicol Appl Pharmacol; 2017 Aug; 329():326-333. PubMed ID: 28624443
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of stroke damage by angiotensin II type 2 receptor stimulation via peroxisome proliferator-activated receptor-gamma activation.
Shan BS; Mogi M; Iwanami J; Bai HY; Kan-No H; Higaki A; Min LJ; Horiuchi M
Hypertens Res; 2018 Oct; 41(10):839-848. PubMed ID: 30089862
[TBL] [Abstract][Full Text] [Related]
20. Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats.
Castoldi G; di Gioia CRT; Roma F; Carletti R; Manzoni G; Stella A; Zerbini G; Perseghin G
Acta Diabetol; 2019 Jan; 56(1):97-104. PubMed ID: 30187136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
